418 results on '"Hurt, Aeron C"'
Search Results
2. Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model
3. Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people
4. A novel and highly divergent Canine Distemper Virus lineage causing distemper in ferrets in Australia
5. Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients
6. Serologic Evidence of Exposure to Highly Pathogenic Avian Influenza H5 Viruses in Migratory Shorebirds, Australia
7. Sustained RNA virome diversity in Antarctic penguins and their ticks
8. Global circulation patterns of seasonal influenza viruses vary with antigenic drift
9. Virome heterogeneity and connectivity in waterfowl and shorebird communities
10. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem
11. Human CD8+ T cell cross-reactivity across influenza A, B and C viruses
12. The impact of climate and antigenic evolution on seasonal influenza virus epidemics in Australia
13. Genetic variations on 31 and 450 residues of influenza A nucleoprotein affect viral replication and translation
14. Cross-lineage protection by human antibodies binding the influenza B hemagglutinin
15. Antiviral Drugs for the Treatment and Prevention of Influenza
16. Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity
17. Meta-transcriptomics reveals a diverse antibiotic resistance gene pool in avian microbiomes
18. Untargeted metabolomics analysis of the upper respiratory tract of ferrets following influenza A virus infection and oseltamivir treatment
19. Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity.
20. Neuraminidase inhibitor resistance in influenza: a clinical perspective
21. TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses
22. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide
23. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016
24. Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution
25. Debate regarding oseltamivir use for seasonal and pandemic influenza
26. Universal anti-neuraminidase antibody inhibiting all influenza A subtypes
27. Proposed Surveillance for Influenza A in Feral Pigs
28. Double dose oseltamivir for severe influenza—does it help? No, we need to seek new and better treatment options
29. Strong host phylogenetic and ecological effects on host competency for avian influenza in Australian wild birds.
30. Investigating the transmission of baloxavir‐resistant influenza viruses from treated index patients to untreated household contacts in the BLOCKSTONE study.
31. Retinoic Acid–Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection.
32. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
33. New options to treat influenza B
34. Combined NKT Cell Activation and Influenza Virus Vaccination Boosts Memory CTL Generation and Protective Immunity
35. The Global Circulation of Seasonal Influenza a (H3N2) Viruses
36. The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay
37. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model
38. Outcomes of Influenza with Treatment in Patients with Diabetes: Subgroup Analysis of the Phase 3 CAPSTONE-2 Trial
39. Evaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infection
40. Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility
41. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014
42. Overview of the 3rd isirv-Antiviral Group Conference – advances in clinical management
43. Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification
44. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013
45. Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact
46. Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses
47. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses
48. Surveillance and analysis of avian influenza viruses, Australia
49. Influenza virus transmission from horses to dogs, Australia
50. Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.